Keywords: glaxo, wellcome, gains, relenza, approval, usa, launch

Glaxo Wellcome gains Relenza approval in USA, launch set for fall

Article | 28 July 1999

Glaxo Wellcome says that it has received approval from the US Food andDrug Administration for its neuraminidase inhibitor Relenza (zanamivir). ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Roche

Go to company listing

Related Drugs

Relenza

Zanamivir

Nystatin

Go to drug listing